Infliximab Therapy Impacts the Peripheral Immune System of Immunomodulator and Corticosteroid Naïve Patients with Crohn's Disease

BACKGROUND/AIMS: Infliximab (IFX), an antibody to tumor necrosis factor, (TNF)-α has efficacy in treating Crohn's disease (CD). However, knowledge of the potential effects of IFX on patients' immune profiles is lacking. The purpose of this study was to reveal the immunological effects of I...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kato, Kyoichi, Fukunaga, Ken, Kamikozuru, Koji, Kashiwamura, Shinichiro, Hida, Nobuyuki, Ohda, Yoshio, Takeda, Naohisa, Yoshida, Koji, Iimuro, Masaki, Yokoyama, Yoko, Kikuyama, Risa, Miwa, Hiroto, Matsumoto, Takayuki
Format: Artigo
Idioma:Inglês
Publicat: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065091/
https://ncbi.nlm.nih.gov/pubmed/21461070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2011.5.1.37
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars